How to Choose a Regulatory and Compliance Consultant

How to Choose a Regulatory and Compliance Consultant

Table of Contents

The regulatory path can make or break a biotech program, and many companies, especially smaller ones, rely on outside regulatory and compliance consultants to navigate it. The right consultant can sharpen your strategy, smooth your interactions with regulators, and help you avoid costly missteps; the wrong one can leave you with generic advice that does not fit your situation. The best regulatory consultant for you is one with deep, specific expertise in your modality, region, and regulatory pathway, a real track record, and the seniority to give your program genuine attention. Here is how to choose.

Clarify what you need

Regulatory and compliance needs vary widely, so start by clarifying what you actually require. You might need help with regulatory strategy (charting the path to approval), specific submissions or interactions with regulators, compliance with quality and other requirements, or specialized guidance for a particular modality or market. The expertise required differs enormously across these, and across therapeutic areas, product types, and regions. Knowing whether you need high-level strategic guidance, hands-on submission support, compliance help, or specialized expertise focuses your search on consultants who genuinely fit, rather than generalists who may not match your specific situation.

What to look for

Evaluate consultants against the factors that determine whether their guidance will actually help.

  • Specific, relevant expertise. Do they have deep experience with your modality, your therapeutic area, your regulatory pathway, and the regions that matter to you? Regulatory expertise is highly specific, and general experience is a poor substitute for direct relevance.
  • Track record. Have they successfully guided programs like yours, with real experience navigating the relevant regulators and pathways?
  • Seniority and attention. Will experienced people actually work on your program, and will you get the attention your situation needs? This is a common point of failure.
  • Strategic and practical. Can they provide both sound strategy and practical, actionable guidance, and communicate it clearly?
  • Fit and communication. Do they understand your specific situation and communicate in a way that works for your team?

Questions to ask

Pointed questions reveal fit fast. Ask about their specific experience with your modality, pathway, and regions, and for relevant examples. Ask who will actually work on your program and how senior they are. Ask how they would approach your specific situation, and gauge whether their thinking is genuinely tailored. Ask about their track record with similar programs and regulators. And clarify engagement terms and how they will work with your team. A strong consultant speaks with specific, relevant expertise and gives tailored answers; a weak one offers generic regulatory platitudes.

Red flags to watch for

Some signals warrant caution. Be wary of consultants who claim broad expertise across everything rather than deep, specific relevance, since regulatory expertise does not generalize well. Watch for a bait-and-switch, where senior people sell the engagement but junior staff do the work. Treat generic advice that does not reflect your specific situation as a warning sign. And be cautious of consultants who cannot demonstrate directly relevant experience. Because regulatory missteps are costly and hard to reverse, ensuring your consultant has genuine, specific expertise and will truly engage with your program is essential.

How to find candidates

To find regulatory and compliance consultants worth evaluating, industry directories let you identify firms and specialists by their focus, so you can build a shortlist of those with relevant expertise. From there, evaluate for specific, relevant experience, a real track record, senior attention, and good fit, and choose the consultant whose expertise genuinely matches your modality, pathway, and needs. Given how consequential regulatory strategy is, this is a decision that rewards seeking out true specialists rather than settling for general capability.

The bottom line

Choosing a regulatory and compliance consultant well means clarifying exactly what you need, then selecting for deep and specific relevant expertise, a real track record, senior attention to your program, and sound, practical, well-communicated guidance. Watch for broad generalist claims, bait-and-switch staffing, and generic advice. Use directories to find specialists, then evaluate for genuine fit. The right consultant can meaningfully improve your path to approval and help you avoid expensive mistakes, which makes choosing one with truly relevant expertise well worth the effort.

How to get the most from the engagement

Choosing a strong regulatory consultant is the beginning; how you use them determines the value you get, and a few practices greatly improve the return on the engagement. The most important is to involve the consultant early, because regulatory strategy is most valuable when it shapes decisions from the start rather than being brought in to fix problems after key choices are made. Engaging a regulatory expert early in your program, so their guidance informs your development strategy, trial design, and regulatory interactions from the outset, lets you avoid costly missteps that are hard to reverse later, which is where much of the value of good regulatory advice lies. Being clear about scope and expectations also matters, so that both you and the consultant understand what they are responsible for, what decisions they are informing, and how they will work with your team, preventing the confusion and gaps that undermine an engagement. Genuine collaboration with your internal team is important too: regulatory strategy touches many parts of a program, so ensuring the consultant works closely with your relevant people, shares context openly, and integrates their guidance into your broader plans produces far better results than treating them as an isolated advisor handing down opinions. It also helps to be honest and thorough in what you share, since a consultant can only give sound, tailored advice if they genuinely understand your situation, including its challenges and uncertainties. And drawing fully on their expertise, treating them as a strategic partner whose experience navigating regulators is valuable, rather than as a box-ticking service, tends to yield the most benefit. Companies that involve their regulatory consultant early, scope the engagement clearly, collaborate genuinely, share openly, and use the consultant’s expertise strategically get far more from the relationship than those who bring in regulatory help late and narrowly. Given how consequential regulatory strategy is, making the most of a good consultant is well worth the effort.

The bottom line

Choosing a regulatory and compliance consultant well means clarifying exactly what you need, then selecting for deep and specific relevant expertise, a real track record, senior attention to your program, and sound, practical, well-communicated guidance, and then getting the most from the engagement by involving them early, scoping clearly, and collaborating genuinely. Watch for broad generalist claims, bait-and-switch staffing, and generic advice, and use directories to find true specialists before evaluating for fit. Because regulatory strategy is so consequential and missteps are costly and hard to reverse, both choosing a consultant with genuinely relevant expertise and using them well from the earliest stages are worth real effort. The right consultant, engaged early and used strategically, can meaningfully improve your path to approval and help you avoid expensive mistakes.

Regulatory needs are ongoing

Remember, too, that regulatory needs rarely end with a single milestone. A program generates regulatory work throughout its life, from strategy through submissions, interactions, and post-approval obligations, so a consultant who understands your program and can support it over time is especially valuable. Choosing a consultant with an eye to a lasting relationship, rather than a single task, means you build up a partner who knows your program deeply and can guide it consistently as new regulatory needs arise, which is more valuable than starting fresh each time.

To find regulatory and compliance consultants for your program, browse the BioMed Nexus regulatory and compliance directory. For related reading, see our explainers on the FDA filings behind drug approval and breakthrough therapy designation.

Frequently asked questions

How do I choose a regulatory consultant for biotech?

Clarify exactly what you need (strategy, submissions, compliance, or specialized guidance), then evaluate consultants on deep and specific expertise in your modality, therapeutic area, pathway, and regions, a relevant track record, senior attention to your program, and clear, practical guidance. Use directories to find specialists, then select for genuine fit rather than general capability.

What should a regulatory consultant have?

Deep, specific expertise directly relevant to your modality, therapeutic area, regulatory pathway, and target regions, since regulatory knowledge is highly specific and general experience is a poor substitute. They should also have a real track record guiding similar programs, provide senior attention rather than delegating to junior staff, and give tailored, practical, clearly communicated advice.

What are red flags in a regulatory consultant?

Be wary of consultants who claim broad expertise across everything rather than deep, specific relevance, a bait-and-switch where senior people sell the engagement but junior staff do the work, generic advice that does not reflect your specific situation, and an inability to demonstrate directly relevant experience. Regulatory missteps are costly, so genuine specialization and real engagement matter.

Featured Articles

IgA Nephropathy Just Turned Into a Three Way Race
Daily Updates

IgA Nephropathy Just Turned Into a Three Way Race

Two weeks ago, Vera Therapeutics beat Vertex to market as the first dual BAFF and APRIL inhibitor approved for IgA nephropathy. We flagged it as a race worth watching. It just became a three way contest. Novartis won full FDA approval for Fabhalta to slow

Read More »

Join 65,000+ Biotech, MedTech, and Pharma Leaders

Your Daily Edge in Biotech, MedTech, and Pharma

Get trusted, high-signal updates every morning
Breakthroughs, trial data, deals, and the news that matters